OTC, Supplement Co-Packaging Potential Could Be Clipped By FDA Proposed Rule
Executive Summary
Innovus Pharmaceuticals is among the firms offering supplements and OTC drugs sold together, an option CRN trade group encourages FDA to allow. FDA will determine on a case-by-case basis whether already available co-packaged OTCs and supplements violate a proposed rule on drug co-packaging.
You may also be interested in...
OTCs Launched On Fluticasone ANDAs, Lidocaine In Monograph
Innovus entering OTC fluticasone market in November; and Rising Biosciences prepares topical OTC pain relief.
OTCs Launched On Fluticasone ANDAs, Lidocaine In Monograph
Innovus entering OTC fluticasone market in November; and Rising Biosciences prepares topical OTC pain relief.
Tech Transfer Roundup: Janssen, Eisai, Apexian, Innovus And More
Johnson & Johnson maintains hectic deal-making pace via RA tie-up with Monash and "diabesity" collaboration with UC San Diego.